ZIVO Bioscience, Inc.
Cash Flow Statement
| Line Item | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-6.1M | $-5.8M | $680.8K | $-10.1M | $-3.2M | $-2.7M | $-7.1M |
| Depreciation & Amortization | $25.0K | $25.0K | $25.0K | $19.5K | $73.8K | $91.4K | — |
| Depreciation | $25.0K | $25.0K | — | — | $73.8K | $91.4K | — |
| Amortization | — | — | — | — | $967 | $967 | $966 |
| Stock-Based Compensation | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-2.5M | $-2.3M | $-2.7M | $-3.0M | $-1.8M | $-1.3M | $-1.4M |
| Investing Activities | |||||||
| Capital Expenditures | — | — | — | $0 | $-3.5K | $-4.7K | $-29.6K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $0 | $0 | $-331.4K | $-3.5K | $-4.7K | $-29.6K |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $3.0M | $2.3M | $2.2M | $3.8M | $1.6M | $1.5M | $1.5M |
| Net Change in Cash | $490.4K | $15.2K | $-491.7K | $446.0K | $-178.5K | $210.1K | $15.6K |
| Free Cash Flow | — | — | — | $-3.0M | $-1.8M | $-1.3M | $-1.4M |